Allakos Cash from Investing (Quarterly) Insights

Allakos Inc (ALLK)

1.45 0.00 (0.00%) USD | NASDAQ | May 17, 16:00

1.45 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	9.029M
December 31, 2023	20.19M
September 30, 2023	31.55M
June 30, 2023	6.121M
March 31, 2023	35.32M
December 31, 2022	-71.48M
September 30, 2022	7.687M
June 30, 2022	78.06M
March 31, 2022	57.41M
December 31, 2021	-57.08M
September 30, 2021	113.09M
June 30, 2021	82.95M
March 31, 2021	4.288M
December 31, 2020	-137.52M
September 30, 2020	-15.30M

Date	Value
June 30, 2020	41.32M
March 31, 2020	115.40M
December 31, 2019	-249.86M
September 30, 2019	-91.51M
June 30, 2019	19.28M
March 31, 2019	10.12M
December 31, 2018	-5.33M
September 30, 2018	-99.32M
June 30, 2018	-46.38M
March 31, 2018	-0.017M
December 31, 2017	-0.013M
September 30, 2017	-0.158M
June 30, 2017	0.00
March 31, 2017	-0.093M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-249.86M

Minimum

Dec 2019

115.40M

Maximum

Mar 2020

-0.0535M

Average

14.15M

Median

Cash from Investing (Quarterly) Benchmarks

Tonix Pharmaceuticals Holding Corp	-0.108M
RAPT Therapeutics Inc	15.89M
NovaBay Pharmaceuticals Inc	1.068M
Palatin Technologies Inc	0.00
iBio Inc	0.00

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-32.54M
Cash from Financing (Quarterly)	0.132M
Free Cash Flow	-119.21M
Free Cash Flow Per Share (Quarterly)	-0.3697
Free Cash Flow Yield	-94.78%